# Johnson & Johnson (JNJ) — Q1-2026 Earnings Results

**Report date:** 2026-04-14 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2026

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.70 | N/A | +1.09% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future performance. They emphasized their commitment to maintaining strong market positions.

**Key quotes:**

> Management expressed confidence in the company's long-term growth strategy.

> They highlighted ongoing investments in innovation and product development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson is performing well in terms of earnings per share, exceeding expectations. However, the lack of revenue data and guidance leaves some uncertainty about the company's overall performance. The stock reaction is currently not available, which makes it difficult to assess immediate investor sentiment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2026_